291 related articles for article (PubMed ID: 1292628)
21. Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck.
Evans GA; Howard OM; Erwin R; Farrar WL
Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):339-42. PubMed ID: 7690544
[TBL] [Abstract][Full Text] [Related]
22. Targets of p56(lck) activity in immature thymoblasts: stimulation of the Ras/Raf/MAPK pathway.
Lin K; Abraham KM
Int Immunol; 1997 Feb; 9(2):291-306. PubMed ID: 9040011
[TBL] [Abstract][Full Text] [Related]
23. The kinase Itk and the adaptor TSAd change the specificity of the kinase Lck in T cells by promoting the phosphorylation of Tyr192.
Granum S; Sundvold-Gjerstad V; Gopalakrishnan RP; Berge T; Koll L; Abrahamsen G; Sørlie M; Spurkland A
Sci Signal; 2014 Dec; 7(355):ra118. PubMed ID: 25492967
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.
Mahabeleshwar GH; Das R; Kundu GC
J Biol Chem; 2004 Mar; 279(11):9733-42. PubMed ID: 14699120
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells.
Vang T; Abrahamsen H; Myklebust S; Enserink J; Prydz H; Mustelin T; Amarzguioui M; Tasken K
Eur J Immunol; 2004 Aug; 34(8):2191-9. PubMed ID: 15259016
[TBL] [Abstract][Full Text] [Related]
26. Contribution of p56lck to the upregulation of cytokine production and T cell proliferation by IL-2 in human CD3-stimulated T cell clones.
Eljaafari A; Dorval I; Soula M; Quelvennec E; Pirenne H; Fagard R; Sterkers G
Cell Immunol; 1995 Jan; 160(1):152-6. PubMed ID: 7842481
[TBL] [Abstract][Full Text] [Related]
27. The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.
Gibson S; August A; Kawakami Y; Kawakami T; Dupont B; Mills GB
J Immunol; 1996 Apr; 156(8):2716-22. PubMed ID: 8609388
[TBL] [Abstract][Full Text] [Related]
28. TCR-induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56(lck) residues.
Nyakeriga AM; Garg H; Joshi A
Cytometry A; 2012 Sep; 81(9):797-805. PubMed ID: 22674786
[TBL] [Abstract][Full Text] [Related]
29. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases.
Chuang E; Lee KM; Robbins MD; Duerr JM; Alegre ML; Hambor JE; Neveu MJ; Bluestone JA; Thompson CB
J Immunol; 1999 Feb; 162(3):1270-7. PubMed ID: 9973379
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of T cell receptor-mediated Th1 cell IFN-gamma production and proliferation by divergent cAMP-mediated redox pathways.
Cochrane R; Clark RB; Huang CK; Cone RE
J Interferon Cytokine Res; 2001 Oct; 21(10):797-807. PubMed ID: 11710991
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
[TBL] [Abstract][Full Text] [Related]
32. Interleukin 2-mediated uncoupling of T cell receptor alpha/beta from CD3 signaling.
Haughn L; Leung B; Boise L; Veillette A; Thompson C; Julius M
J Exp Med; 1998 Nov; 188(9):1575-86. PubMed ID: 9802969
[TBL] [Abstract][Full Text] [Related]
33. The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signaling in T cells.
Sade H; Krishna S; Sarin A
J Biol Chem; 2004 Jan; 279(4):2937-44. PubMed ID: 14583609
[TBL] [Abstract][Full Text] [Related]
34. The Src-family kinase, Fyn, regulates the activation of phosphatidylinositol 3-kinase in an interleukin 2-responsive T cell line.
Karnitz LM; Sutor SL; Abraham RT
J Exp Med; 1994 Jun; 179(6):1799-808. PubMed ID: 7515100
[TBL] [Abstract][Full Text] [Related]
35. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
[TBL] [Abstract][Full Text] [Related]
36. Efficient CD28 signalling leads to increases in the kinase activities of the TEC family tyrosine kinase EMT/ITK/TSK and the SRC family tyrosine kinase LCK.
Gibson S; Truitt K; Lu Y; Lapushin R; Khan H; Imboden JB; Mills GB
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1123-8. PubMed ID: 9494076
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of expression of the CD45 tyrosine protein phosphatase on the tyrosine phosphorylation of the lck, fyn, and c-src tyrosine protein kinases.
Hurley TR; Hyman R; Sefton BM
Mol Cell Biol; 1993 Mar; 13(3):1651-6. PubMed ID: 8441403
[TBL] [Abstract][Full Text] [Related]
38. Lck is involved in interleukin-2 induced proliferation but not cell survival in human T cells through a MAP kinase-independent pathway.
Brockdorff J; Nielsen M; Kaltoft K; Mustelin T; Röpke C; Svejaard A; Geisler C; Odum N
Eur Cytokine Netw; 2000 Jun; 11(2):225-31. PubMed ID: 10903801
[TBL] [Abstract][Full Text] [Related]
39. Induction of interleukin 2-responsiveness in thymocytes of the transgenic mice carrying lck-transgene.
Moroi Y; Koga Y; Nakamura K; Ohtsu M; Kimura G; Nomoto K
Microbiol Immunol; 1993; 37(5):369-81. PubMed ID: 8102775
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the T-cell receptor-mediated signal transduction by microinjection of anti-Lck monoclonal antibody into T-cells.
Nakamura K; Koga Y; Yoshida H; Tanaka K; Sasaki M; Kimura G; Nomoto K
Biochim Biophys Acta; 1994 Dec; 1224(3):495-505. PubMed ID: 7803509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
